olivLaw · US equity research
eHealth, Inc. EHTH
Insurance Agents, Brokers & Service · SIC 6411 · Vertical: Insurance Agents, Brokers & Service (SIC 6411)
eHealth is a private health insurance marketplace that guides consumers through enrollment in Medicare, individual, family and employer plans, earning commissions from insurance carriers. In 2026 the company is restructuring around a lifetime advisory model, and revenue fell 45% year-over-year in Q2 2026, with full-year guidance of 405.0 to 445.0 million USD.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, eHealth, Inc. (EHTH) stock was 0.63 USD (+9.43% on the day), with market capitalisation 20.3 m USD, beta 1.39, 52-week range 0.49–5.08 USD. Latest reported quarter (Q2 2026): revenue of 33.6 m USD (−44.8% YoY), net income of -23.6 m USD, diluted EPS -1.18 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 49.1
- neutral
- Bollinger (20, 2)
- 0.47 – 0.70
- in the upper half of the band · %B 0.71 · band width 40.4%
- SMA 50 / 200
- 0.78 / 1.49
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.07 / -0.09
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −6.7% | −1.1% | −5.6 pp | — |
| 3 months | −49.6% | −0.5% | −49.2 pp | — |
| 6 months | −68.3% | +4.4% | −72.7 pp | — |
| Year to date | −86.2% | +12.3% | −98.5 pp | — |
| 1 year | −87.1% | +13.5% | −100.7 pp | +0.8% |
| 3 years | −92.6% | +76.4% | −169.0 pp | +4.3% |
| 5 years | −98.4% | +63.7% | −162.1 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 58.4 m | 315.2 m | 113.1 m | 60.8 m | 53.9 m | 326.2 m | 88.0 m | 33.6 m |
| Gross profit | -3.8 m | 163.9 m | 41.7 m | 18.9 m | -180.0 k | 180.3 m | 36.7 m | 5.1 m |
| Operating income | -43.2 m | 112.6 m | 4.8 m | -23.0 m | -41.5 m | 126.3 m | -2.9 m | -27.5 m |
| Depreciation & amortisation | 3.8 m | — | — | — | — | — | — | — |
| Interest expense | 2.9 m | 2.6 m | 2.6 m | 2.3 m | 2.4 m | 3.4 m | 4.0 m | 4.1 m |
| Pre-tax income | -44.4 m | 110.5 m | 3.7 m | -24.1 m | -42.9 m | 122.0 m | -6.1 m | -30.7 m |
| Income tax | -1.9 m | 13.0 m | 1.8 m | -6.7 m | -11.2 m | 34.8 m | -1.4 m | -7.1 m |
| Net income | -42.5 m | 97.5 m | 2.0 m | -17.4 m | -31.7 m | 87.2 m | -4.7 m | -23.6 m |
| Diluted EPS | -1.83 | 3.28 ≈ | -0.33 | -0.98 | -1.46 | 2.82 ≈ | -0.58 | -1.18 |
| Operating cash flow | -29.3 m ≈ | -27.7 m | 77.1 m | -41.2 m ≈ | -25.3 m ≈ | -35.9 m | 35.8 m | -5.0 m ≈ |
| Capex | 998.0 k ≈ | 631.0 k | 308.0 k | 1.6 m ≈ | 214.0 k ≈ | 143.0 k | 155.0 k | 488.0 k ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 251.4 m | 506.2 m | 582.8 m | 538.2 m | 405.4 m | 452.9 m | 532.4 m | 554.0 m |
| Revenue YoY | +31.8% | +101.4% | +15.1% | −7.6% | −24.7% | +11.7% | +17.6% | +4.1% |
| Net income | 241.0 k | 66.9 m | 45.5 m | -104.4 m | -88.7 m | -28.2 m | 10.1 m | 40.0 m |
| Net income YoY | −99.1% | +27,653.9% | −32.0% | −329.6% | unavailable | unavailable | unavailable | +298.2% |
| Diluted EPS | 0.01 | 2.73 | 1.68 | -4.59 | -4.36 | -2.37 | -1.19 | -0.34 |
| Diluted EPS YoY | −99.2% | +27,200.0% | −38.5% | −373.2% | unavailable | unavailable | unavailable | unavailable |
| net % | 0.1% | 13.2% | 7.8% | -19.4% | -21.9% | -6.2% | 1.9% | 7.2% |
| Free cash flow | -7.8 m | -78.1 m | -115.6 m | -166.5 m | -27.1 m | -8.8 m | -20.5 m | -27.6 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 73.7 m USD
- Financial debt
- 113.0 m USD
- Net debt
- 39.2 m USD
- Equity
- 591.6 m USD
- Total assets
- 1.3 bn USD
- Debt / equity
- 0.19x
- Current ratio
- 3.37x
- ROE
- 6.8%
- ROA
- 3.3%
- FCF margin
- -5.0%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 582.8 m | 538.2 m | 405.4 m | 452.9 m | 532.4 m | 554.0 m | SEC (XBRL)· 26 Feb 2026verified |
| Cost of revenue | 4.1 m | 2.0 m | 1.6 m | 1.8 m | 1.8 m | 1.3 m | SEC (XBRL)· 26 Feb 2026verified |
| Gross profit | 578.7 m ≈ | 536.2 m ≈ | 403.7 m ≈ | 159.2 m | 208.5 m | 240.8 m | SEC (XBRL)· 26 Feb 2026verified |
| Research & development | 9.1 m | 10.4 m | 12.1 m | 13.7 m | 12.4 m | 13.8 m | SEC (XBRL)· 26 Feb 2026verified |
| Operating income | 53.3 m | -125.6 m | -102.7 m | -29.1 m | 23.6 m | 66.5 m | SEC (XBRL)· 26 Feb 2026verified |
| Depreciation & amortisation | 11.5 m | 18.3 m | 21.1 m | 19.9 m | — | — | SEC (XBRL)· 29 Feb 2024verified |
| EBITDA | 64.8 m ≈ | -107.3 m ≈ | -81.6 m ≈ | -9.2 m ≈ | — | — | SEC (XBRL)· 29 Feb 2024derived |
| Interest expense | — | 845.0 k | 7.6 m | 11.0 m | 11.2 m | 10.8 m | SEC (XBRL)· 26 Feb 2026verified |
| Pre-tax income | 54.0 m | -124.9 m | -106.4 m | -30.6 m | 19.3 m | 58.7 m | SEC (XBRL)· 26 Feb 2026verified |
| Income tax | 8.5 m | -20.5 m | -17.7 m | -2.4 m | 9.3 m | 18.7 m | SEC (XBRL)· 26 Feb 2026verified |
| Net income | 45.5 m | -104.4 m | -88.7 m | -28.2 m | 10.1 m | 40.0 m | SEC (XBRL)· 26 Feb 2026verified |
| Diluted EPS | 1.68 | -4.59 | -4.36 | -2.37 | -1.19 | -0.34 | SEC (XBRL)· 26 Feb 2026verified |
| Weighted average diluted shares | 27.0 m | 26.8 m | 27.4 m | 28.0 m | 29.3 m | 30.5 m | SEC (XBRL)· 26 Feb 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Revenue − Cost of revenue; Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 43.8 m | 81.9 m | 144.4 m | 115.7 m | 39.2 m | 73.7 m | SEC (XBRL)· 26 Feb 2026verified |
| Receivables | 1.8 m | 5.8 m | 2.6 m | 4.0 m | 16.8 m | 7.7 m | SEC (XBRL)· 26 Feb 2026verified |
| Current assets | 331.0 m | 407.6 m | 401.1 m | 382.4 m | 354.5 m | 334.4 m | SEC (XBRL)· 26 Feb 2026verified |
| Property, plant & equipment, net | 14.6 m | 12.1 m | 5.5 m | 4.9 m | 4.4 m | 4.5 m | SEC (XBRL)· 26 Feb 2026verified |
| Goodwill | 40.2 m | 0 | 0 | 0 | — | — | SEC (XBRL)· 29 Feb 2024verified |
| Intangibles (excl. goodwill) | 8.6 m | 1.9 m | — | — | — | — | SEC (XBRL)· 01 Mar 2022verified |
| Total assets | 1.0 bn | 1.1 bn | 1.1 bn | 1.1 bn | 1.2 bn | 1.3 bn | SEC (XBRL)· 26 Feb 2026verified |
| Accounts payable | 36.9 m | 13.8 m | 6.7 m | 7.2 m | 23.4 m | 28.3 m | SEC (XBRL)· 26 Feb 2026verified |
| Short-term debt | — | — | — | 0 | 0 | — | SEC (XBRL)· 07 May 2025verified |
| Long-term debt | — | 0 | 66.1 m | 67.8 m | 68.5 m | 113.0 m | SEC (XBRL)· 26 Feb 2026verified |
| Current liabilities | 84.4 m | 75.5 m | 60.6 m | 78.5 m | 96.0 m | 99.1 m | SEC (XBRL)· 26 Feb 2026verified |
| Total liabilities | 202.5 m | 167.2 m | 198.4 m | 209.3 m | 229.5 m | 288.8 m | SEC (XBRL)· 26 Feb 2026verified |
| Equity | 837.6 m † | 749.5 m † | 651.0 m † | 606.0 m † | 588.4 m † | 591.6 m † | SEC (XBRL)· 26 Feb 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -107.9 m | -162.6 m | -26.9 m | -6.7 m | -18.4 m | -25.3 m | SEC (XBRL)· 26 Feb 2026verified |
| Capex | 7.8 m | 3.9 m | 214.0 k | 2.1 m | 2.1 m | 2.3 m | SEC (XBRL)· 26 Feb 2026verified |
| Free cash flow | -115.6 m ≈ | -166.5 m ≈ | -27.1 m ≈ | -8.8 m ≈ | -20.5 m ≈ | -27.6 m ≈ | SEC (XBRL)· 26 Feb 2026derived |
| Investing cash flow | -73.3 m | -12.6 m | 25.9 m | -15.9 m | -48.4 m | 25.4 m | SEC (XBRL)· 26 Feb 2026verified |
| Financing cash flow | 201.2 m | 213.2 m | 63.8 m | -6.2 m | -9.7 m | 34.3 m | SEC (XBRL)· 26 Feb 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 50.0% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 20.3 m USD
Key indicators
Coverage and freshness
Score by group
50% · Insufficient data
Estimated value range
unavailable — no valuation method could be computed
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
- DCF (discounted cash flow)unavailable · the base of the ratio is not positive
- Peers: EV/EBITDAunavailable · input data missing
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
no valuation method could be computed
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 50.0% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 6.1% | 43 (vs peers) | 21% |
| Net margin · Quality | 5.4% | 55 (vs peers) | 13% |
| FCF conversion · Quality | -115.7% | 0 (on a fixed band) | 13% |
| Revenue CAGR 3Y · Growth | 11.0% | 91 (on a fixed band) | 17% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | 3.9x | 37 (on a fixed band) | 13% |
| Current ratio · Balance sheet | 9.9x | 100 (on a fixed band) | 8% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | -154.7% | 0 (on a fixed band) | 17% |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet62/100 · 2/3 factors with a value
- Growth· partial91/100 · 1/2 factors with a value
- Quality35/100 · 3/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partial0/100 · 1/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
eHealth, Inc (EHTH). Latest full fiscal year: 2025; data up to 2026-06-30.
Figures computed from the financial statements: revenue 554.0 m USD in 2025; YoY growth 4.1%; net margin 5.4%; ROE 5.0%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (score weight coverage: 50.0% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Revenue CAGR 3Y: 11.0%
- Current ratio: 9.9x
What contradicts it
- FCF conversion: -115.7%
- FCF yield: -154.7%
Not assessed (insufficient data or a ratio without meaning): EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Insurance Agents, Brokers & Service (SIC 6411) · same industry (4-digit SIC) · compared with 29 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| MRSHMarsh & Mclennan Companies, Inc. | 100.0 bn | 25.2 | 26.7% | 14.2% | +10.3% | +15% / +5% |
| XHGXChange TEC.INC | 85.9 bn | — | — | -204.9% | +24.9% | +253% / −100% |
| AJGArthur J. Gallagher & Co. | 73.9 bn | 47.1 | 6.7% | 10.0% | +20.7% | +16% / +16% |
| AONAon plc | 73.1 bn | 18.9 | 43.6% | 22.2% | +9.4% | −3% / +5% |
| WTWWillis Towers Watson PLC | 31.1 bn | 20.5 | 20.2% | 15.2% | −2.2% | +5% / +37% |
| BROBrown & Brown, Inc. | 24.5 bn | 22.1 | 9.7% | 17.6% | +22.8% | −8% / −1% |
| EQHEquitable Holdings, Inc. | 15.3 bn | — | -508.8% | -8.7% | −6.1% | +20% / +83% |
| AIFUAIFU Inc. | 10.5 bn | — | -155.9% | -408.8% | −67.9% | −84% / −100% |
| ACTEnact Holdings, Inc. | 6.6 bn | 10.7 | 12.7% | 53.8% | +2.8% | +25% / +74% |
| HGTYHagerty, Inc. | 6.5 bn | 108.0 | 25.6% | 4.4% | +17.3% | +40% / +121% |
| RYANRyan Specialty Holdings, Inc. | 5.2 bn | 49.9 | 19.4% | 3.2% | +21.3% | −18% / +4% |
| CRVLCorvel Corporation | 4.4 bn | 38.9 | 30.7% | 11.7% | +7.0% | +19% / +26% |
| WDHWaterdrop Inc. | 3.6 bn | 50.5 | 11.6% | 14.2% | +49.8% | −44% / −16% |
| ARXAccelerant Holdings | 3.3 bn | — | -241.6% | -112.1% | +51.5% | +36% / unavailable |
| NPNeptune Insurance Holdings Inc. | 2.7 bn | 91.6 | — | 22.7% | +33.7% | +22% / unavailable |
| GSHDGoosehead Insurance, Inc. | 1.2 bn | 33.8 | — | 8.8% | +16.2% | −21% / −23% |
| HUIZHuize Holding Limited | 1.1 bn | — | 1.0% | 0.3% | +32.2% | −31% / −48% |
| BWINThe Baldwin Insurance Group, Inc. | 1.1 bn | — | -10.7% | -4.7% | +8.3% | +13% / +84% |
| RDZNRoadzen Inc. | 92.8 m | — | — | -46.9% | +24.2% | −37% / −78% |
| SLQTSelectQuote, Inc. | 88.1 m | 7.3 | 23.4% | 4.6% | +6.0% | −66% / −61% |
| EHTHeHealth, Inc | 20.3 m | — | 5.0% | 5.4% | +4.1% | −87% / −93% |
| EZRAReliance Global Group, Inc. | 2.4 m | — | -123.4% | -54.3% | −11.6% | −91% / −100% |
| LIFEEthos Technologies Inc. | 0 | — | -50.8% | -16.2% | +52.0% | unavailable / unavailable |
| CRD-ACrawford & Co | — | — | 14.0% | 2.0% | −2.2% | +7% / +7% |
| YBYuanbao Inc. | — | — | 152.7% | 29.9% | +33.1% | −43% / unavailable |
1- and 3-year price returns: for EHTH from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 15.75 Total return 2,381% · Per year 2,381% | 27.76 Total return 4,274% · Per year 4,274% | 41.70 Total return 6,470% · Per year 6,470% |
| 3 years | 17.34 Total return 2,632% · Per year 201% | 34.19 Total return 5,286% · Per year 278% | 56.09 Total return 8,737% · Per year 345% |
| 5 years | 19.09 Total return 2,907% · Per year 98% | 42.10 Total return 6,534% · Per year 131% | 75.44 Total return 11,786% · Per year 160% |
- Exit P/E± 8.55
- Net margin± 5.98
- Annual revenue growth± 4.62
- Annual dilution± 0.50
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 05 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results).
In brief
eHealth is a private health insurance marketplace that guides consumers through enrollment in Medicare, individual, family and employer plans, earning commissions from insurance carriers. In 2026 the company is restructuring around a lifetime advisory model, and revenue fell 45% year-over-year in Q2 2026 3, with full-year guidance of 405.0 to 445.0 million USD 3.
SWOT
Strengths
- The omnichannel platform and plan recommendation tools differentiate the offering in the market 1.
- Long-standing carrier relationships and back-office integration support efficient application processing 1.
- The model carries no underwriting risk and does not charge consumers directly, which limits financial exposure 1.
Weaknesses
Opportunities
Risks
- Carrier dependencehigh
Relationships are non-exclusive and can end on short notice, which could quickly reduce plan availability 1.
- Medicare regulationhigh
Enrollment and commission rules change often, and non-compliance can lead carriers to require corrective action 1.
- Customer acquisition costmedium
If digital traffic falls or costs rise, marketing efficiency could decline 1.
- Communications compliancemedium
Calls, emails and texts are subject to strict laws, and violations can create significant liability 1.
- Liquidity and commissions receivablemedium
The commissions receivable balance is large relative to available cash, and its realization depends on member retention 3.
Investment thesis
What would need to be true (bull case)
What to watch
- Q3 2026 results and Medicare enrollment trendsQ3 2026
- Delivery against 2026 revenue and adjusted EBITDA guidance2026
- ICHRA progress and expansion of broker partnerships2027
- Evolution of commissions receivable and operating cash flownext 10-K
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 05 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results).
The business
eHealth, Inc. presents itself as a private health insurance marketplace with a technology and service platform offering consumers education and enrollment solutions 1. It earns revenue from commissions paid by insurance carriers, the platform being free to consumers, and it does not take on underwriting risk 1. The platform includes over 180 carriers nationwide 1.
The omnichannel model lets consumers enroll online, by telephone with a licensed agent, or through a hybrid interaction with live chat and co-browsing 1. The plan recommendation tool analyzes beneficiaries' health information against plan data 1. The company has integrated artificial intelligence into its telephonic platform to reduce wait times 1.
Segments
Market context
The US health insurance market rests on Medicare, ACA programs and employer plans, and consumers increasingly compare options online 1. Roughly 10,000 people age into Medicare daily, supporting long-term demand for Medicare Advantage 1. In the near term, carrier cost pressures and regulatory changes are reducing enrollment volume 1.
Consumer search is shifting toward AI-assisted tools, which may change how platforms reach customers 1. If organic traffic declines, customer acquisition costs could rise and the company could need alternative channels 1.
Trends
- Medicare Advantage carrier pressuremixed
Carriers are scaling back growth and changing compensation structures, which could limit plan availability and eHealth's revenue 1. In the 2025 enrollment period carriers reacted to high medical costs, and commission rates rose for eHealth 1.
- Medicare regulatory changesheadwind
Removing the special enrollment period for dual-eligible and LIS beneficiaries reduced Medicare enrollments outside the annual period, and standalone Part D plans declined sharply 1. If regulation keeps narrowing enrollment, volume could stay low 1.
- Ageing population and Medicare demandtailwind
A large number of people enter Medicare each day, and the value proposition of Medicare Advantage remains attractive to consumers 1. This could support long-term growth if enrollments recover 1.
- Marketing costs and digital competitionheadwind
Rising acquisition costs and changing online search reduce the efficiency of traditional channels, and the company has cut variable marketing spend 12. If digital visibility cannot be restored, spending could rise without a matching increase in enrollments 1.
Competitive position
eHealth competes with government insurance exchanges, direct-to-consumer channels, national telesales brokers, online lead generators and local agents 1. Many carriers sell directly through call centers and their own websites, and some competitors have larger financial and marketing resources 1.
Carrier relationships are non-exclusive and can be terminated on short notice, so portfolio changes can quickly affect offerings and revenue 1. Differentiation rests on back-office integration with many carriers and the omnichannel model 1.
- Government Medicare and ACA exchanges
Compete through official enrollment channels that offer consumers a direct route to coverage 1.
- Carriers that sell directly
Sell plans through call centers and their own websites, potentially bypassing the eHealth platform 1.
- National telesales brokers
Compete for the same consumers with sales teams and marketing resources 1.
- Online lead generators
Capture search traffic and can steer consumers toward competing plans 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report04 Nov 2026Results of operations · Financial statements and exhibits
- Current report16 Oct 2026Delisting notice
- Quarterly report05 Aug 2026
- Current report04 Aug 2026Results of operations · Financial statements and exhibits
- Current report25 Jun 2026Departure or appointment of officers · Shareholder vote · Financial statements and exhibits
- Quarterly report07 May 2026
- Current report06 May 2026Results of operations · Departure or appointment of officers · Financial statements and exhibits
- Proxy statement28 Apr 2026
- Current report31 Mar 2026Departure or appointment of officers · Financial statements and exhibits
- Annual report26 Feb 2026
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / eHealth, Inc. · 26 Feb 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / eHealth, Inc. · 05 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / eHealth, Inc. · 04 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.